Holen Sie sich die Stockscreener-App
15.52
5.51%
0.81
Handel nachbörslich:
15.37
-0.15
-0.97%
Schlusskurs vom Vortag:
$14.71
Offen:
$14.82
24-Stunden-Volumen:
675.87K
Relative Volume:
0.69
Marktkapitalisierung:
$758.11M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-695.98M
KGV:
-0.0472
EPS:
-328.6331
Netto-Cashflow:
$-143.65M
1W Leistung:
+7.93%
1M Leistung:
-14.02%
6M Leistung:
-25.78%
1J Leistung:
+28.41%
1-Tages-Spanne:
$14.71
$15.60
1-Wochen-Bereich:
$13.66
$15.60
52-Wochen-Spanne:
$2.622
$65.80
Vor Biopharma Inc Stock (VOR) Company Profile
Firmenname
Vor Biopharma Inc
Sektor
Branche
Telefon
617-655-6580
Adresse
500 BOYLSTON STREET, BOSTON
Compare VOR vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VOR
Vor Biopharma Inc
|
15.52 | 718.55M | 0 | -695.98M | -143.65M | -328.63 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 109.34B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 74.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 50.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 39.78B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.02B | 5.36B | 287.73M | 924.18M | 2.5229 |
Vor Biopharma Inc Stock (VOR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-30 | Eingeleitet | Jefferies | Buy |
| 2026-03-19 | Eingeleitet | Wells Fargo | Overweight |
| 2026-01-09 | Eingeleitet | Citigroup | Buy |
| 2025-12-17 | Eingeleitet | TD Cowen | Buy |
| 2025-12-09 | Eingeleitet | JP Morgan | Overweight |
| 2025-11-25 | Fortgesetzt | Wedbush | Neutral |
| 2025-10-15 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-09-24 | Hochstufung | Stifel | Hold → Buy |
| 2025-06-30 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2022-07-26 | Eingeleitet | Wedbush | Outperform |
| 2022-04-27 | Eingeleitet | Goldman | Neutral |
| 2021-12-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-12-03 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-12-02 | Eingeleitet | Oppenheimer | Outperform |
| 2021-10-19 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-03-25 | Eingeleitet | B. Riley Securities | Buy |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-03-03 | Eingeleitet | Evercore ISI | Outperform |
| 2021-03-02 | Eingeleitet | Goldman | Sell |
| 2021-03-02 | Eingeleitet | Stifel | Buy |
Alle ansehen
Vor Biopharma Inc Aktie (VOR) Neueste Nachrichten
Six new Vor Bio hires get stock awards priced at $13.85 - Stock Titan
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Jefferies Financial Group Upgrades Vor Biopharma (NASDAQ:VOR) to Strong-Buy - MarketBeat
Vor Biopharma Inc. (NASDAQ:VOR) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Vor Biopharma Inc. (NASDAQ:VOR) Short Interest Down 17.3% in April - MarketBeat
Vor Biopharma (NASDAQ: VOR) files resale registration for 5.34M shares - Stock Titan
Vor Biopharma (NASDAQ: VOR) plans virtual 2026 meeting and equity plan changes - Stock Titan
[ARS] Vor Biopharma Inc. SEC Filing - Stock Titan
Vor Biopharma Shares Skyrocket on Global Licensing Deal for Autoimmune Therapy - MSN
Wall Street analysts predict a 107.82% upside in Vor Biopharma (VOR): Here's what you should know - MSN
Vor Bio announces $75M private placement - MSN
Vor Biopharma (NASDAQ:VOR) Director Ra Capital Management, L.P. Sells 165,150 Shares - MarketBeat
Ra capital healthcare fund sells 165,150 Vor Biopharma shares for $2.6m By Investing.com - Investing.com Australia
Ra capital healthcare fund sells 165,150 Vor Biopharma shares for $2.6m - Investing.com UK
RA Capital fund trims Vor Biopharma (NASDAQ: VOR) stake with 165,150-share sale - Stock Titan
VOR shares rally over 40% in pre-market trade after JPMorgan initiates bullish coverage - MSN
Vor Biopharma (VOR) Cost Structure | Q4 2025: EPS Exceeds ExpectationsGDR - Xã Vĩnh Công
Vor Biopharma(VOR.US) 10% Shareholder Sells US$10.17 Million in Common Stock - Moomoo
Ra Capital sells $10.17 million of Vor Biopharma common stock By Investing.com - Investing.com Australia
RA CAPITAL MANAGEMENT, L.P. Increases Stake in Vor Biopharma Inc - GuruFocus
Vor Biopharma (NASDAQ:VOR) Director Sells $7,462,931.08 in Stock - MarketBeat
Insider Selling: Vor Biopharma (NASDAQ:VOR) Director Sells 171,963 Shares of Stock - MarketBeat
Ra Capital sells $10.17 million of Vor Biopharma common stock - Investing.com
RA Capital trims Vor Biopharma (VOR) stake, still owns 19.9% - Stock Titan
RA Capital fund trims Vor Biopharma (VOR) stake with 630K-share sale - Stock Titan
Vor Biopharma (NASDAQ:VOR) Shares Down 4.4%Here's What Happened - MarketBeat
Vor Biopharma (VOR) Stock Volume Stability (Drops Sharply) 2026-04-20High Attention Stocks - Cổng thông tin điện tử tỉnh Tây Ninh
Does Vor Biopharma (VOR) Have the Potential to Rally 117% as Wall Street Analysts Expect? - Yahoo Finance
Vor Biopharma (VOR) Stock: Is It Respecting Levels (Investor Interest) 2026-04-18Index Investing - Cổng thông tin điện tử Tỉnh Sơn La
Vor Biopharma (NASDAQ:VOR) Trading 9.7% HigherWhat's Next? - MarketBeat
Jeremy Brett Sokolove Net Worth (2026) - GuruFocus
Vor Biopharma Q1 EPS Estimate Increased by HC Wainwright - MarketBeat
H.C. Wainwright Maintains Vor Biopharma(VOR.US) With Buy Rating, Cuts Target Price to $31 - Moomoo
VOR Forecast, Price Target & Analyst Ratings | VOR BIOPHARMA INC (NASDAQ:VOR) - ChartMill
VOR Maintains Buy Rating by HC Wainwright & Co. -- Price Target Lowered to $31 - GuruFocus
Ra Capital Management, L.P. Sells 530,610 Shares of Vor Biopharma (NASDAQ:VOR) Stock - MarketBeat
RA Capital sells Vor Biopharma (VOR) shares worth $11.8 million By Investing.com - Investing.com India
RA Capital sells Vor Biopharma (VOR) shares worth $11.8 million - Investing.com
Insider Selling: Vor Biopharma (NASDAQ:VOR) Director Sells 153,735 Shares of Stock - MarketBeat
Vor Biopharma (NASDAQ:VOR) Director Sells $858,840.44 in Stock - MarketBeat
RA Capital reports 19.9% Vor Biopharma (VOR) stake after share sales - Stock Titan
RA Capital entities trim Vor Biopharma (VOR) stake with 738K-share open-market sale - Stock Titan
Finanzdaten der Vor Biopharma Inc-Aktie (VOR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.14%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):